10-K: TruBridge, Inc. Outlines Amended Incentive Plan and Reports 2023 Financial Results
Annual Results
TruBridge, Inc. details its amended 2019 Incentive Plan and reports a 4% revenue increase for 2023, alongside a net loss due to impairment charges and restructuring costs.
Summary
- TruBridge, Inc., formerly Computer Programs and Systems, Inc., has released its amended 2019 Incentive Plan.
- The plan aims to attract and retain key personnel, align their interests with stockholders, and promote business success.
- Eligible recipients include employees, consultants, and directors.
- Available awards include stock options, stock appreciation rights, restricted awards, performance share awards, cash awards, and other equity-based awards.
- The company reported a 4% increase in revenue for 2023, reaching $339.4 million.
- However, the company experienced a net loss of $45.8 million, a significant decrease from the $15.9 million net income in 2022.
- This loss was primarily due to $35.9 million in goodwill impairment charges, $2.3 million in trademark impairment charges, $17.7 million in severance and restructuring costs, and $6.2 million in increased interest expenses.
- The company's RCM segment saw an 8% revenue increase, while the EHR segment experienced a 1% decrease.
- The company's patient engagement segment saw a 7% revenue increase.
- The company's twelve-month backlog is approximately $9 million in non-recurring system purchases and $328 million in recurring payments under support and maintenance and RCM services.
Sentiment
Score: 3
Explanation: The document presents a mixed picture with positive revenue growth but significant losses and challenges. The negative financial results and risks outweigh the positives, leading to a low sentiment score.
Positives
- The amended 2019 Incentive Plan is designed to attract and retain key personnel.
- The company's RCM segment saw an 8% revenue increase.
- The patient engagement segment's revenue increased by 7%.
Negatives
- The company experienced a net loss of $45.8 million in 2023.
- Goodwill impairment charges totaled $35.9 million.
- Trademark impairment charges totaled $2.3 million.
- Severance and restructuring costs amounted to $17.7 million.
- Interest expenses increased by $6.2 million.
- The EHR segment's revenue decreased by 1%.
Risks
- The company faces risks related to industry saturation, hospital consolidations, and unfavorable economic conditions.
- There are risks associated with the transition to a subscription-based revenue model and technology modernization.
- The company faces competition from companies with greater resources.
- Potential future acquisitions may be expensive and time-consuming.
- The company may face challenges in attracting and retaining qualified personnel.
- There are risks related to the development of new products and the maintenance of current products.
- The company is exposed to claims for breaches of security and viruses in its systems.
- The company may face service interruptions due to loss of power or telecommunications.
- The company's substantial indebtedness may adversely affect its business operations.
- The company is exposed to market risk related to interest rate changes.
- The company may be vulnerable to significant damage from natural disasters.
Future Outlook
The company expects its ongoing shift from a software license model to a subscription-based services revenue model to create a recurring revenue stream that is more predictable. The company also expects continued growth in demand for its RCM and related services.
Management Comments
- The plan aims to attract and retain key personnel, align their interests with stockholders, and promote business success.
- The company is focused on cross-selling RCM solutions and services into its existing EHR client base.
- The company is also focused on expanding its RCM market share with sales to new community hospitals and larger health systems.
- The company is pursuing competitive and vulnerable EHR replacement opportunities.
- The company is focused on identifying new innovation and larger adjacency opportunities, driven by demand for patient engagement, industry insights, reporting and analytics technology.
Industry Context
The healthcare industry is facing challenges such as changing economic dynamics, increased regulation, and pressure to improve the quality of care. These factors create an environment of escalating costs, which, because of their heavy reliance on Medicare and Medicaid programs, our hospital clients have limited ability to recover through reimbursement changes. The company believes that healthcare providers can successfully address these issues with the help of advanced medical information systems, including RCM solutions and complementary services.
Comparison to Industry Standards
- The company's main competitors in the RCM solutions market include RelayHealth Corp, SSI Group, LLC, Quadax Inc., Change Healthcare Holdings, Inc., Availity, LLC, Waystar Technologies, Inc., and Navicure, Inc.
- The company's main competitors in the business management, consulting and managed IT services market are Resolution Health, Inc., The Outsource Group Inc., Patient Focus, Inc., Xtend Healthcare Inc., Ensemble Health Partners, and nThrive, Inc.
- The company's main competitors in the acute care EHR market are Oracle Cerner Corporation, Medical Information Technology, Inc. (Meditech), and MEDHOST, Inc.
- The company's main competitors in the patient engagement market include Relay Health, Get Well Network/Healthloop, Apollo Care Connect, Bridge Patient Portal, eClinicalWorks Patient Portal, Influence Health, and InteliChart.
- Many of these competitors are more established and have greater financial, technical, and marketing resources than TruBridge.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer, Secretary and Treasurer | NA | Vinay Bassi | January 1, 2024 | New appointment |
Stakeholder Impact
- Shareholders will be impacted by the net loss and potential stock price volatility.
- Employees may be affected by restructuring and changes in compensation plans.
- Customers may experience changes in service delivery as the company transitions to new models.
- Suppliers may be impacted by changes in the company's financial performance.
- Creditors may be concerned about the company's ability to service its debt.
Next Steps
- The company will continue to focus on cross-selling RCM services to its existing EHR customer base.
- The company will continue to expand its RCM market share with sales to new community hospitals and larger health systems.
- The company will continue to pursue competitive and vulnerable EHR replacement opportunities.
- The company will continue to identify new innovation and larger adjacency opportunities, driven by demand for patient engagement, industry insights, reporting and analytics technology.
Key Dates
| Date | Description |
|---|---|
| March 7, 2019 | Date the 2019 Incentive Plan was originally adopted by the Board. |
| April 29, 2019 | Date the 2019 Incentive Plan was approved by the stockholders. |
| March 10, 2022 | Date the Amended and Restated 2019 Incentive Plan was adopted by the Board. |
| May 12, 2022 | Date the Amended and Restated 2019 Incentive Plan was approved by the stockholders. |
| December 31, 2023 | End of the fiscal year for the reported financial results. |
| March 4, 2024 | Date of the corporate name change to TruBridge, Inc. |
Keywords
Incentive Plan, Revenue Cycle Management, Electronic Health Record, Patient Engagement, Financial Results, Stock Options, Restricted Stock, Performance Awards, Goodwill Impairment, Healthcare IT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.